A Food and Drug Administration (FDA) advisory committee voted unanimously on Thursday (Oct. 14) to recommend a Moderna COVID-19 vaccine booster for people who are 65 years of age or older and younger adults who are at high-risk of severe disease or complications due to medical conditions or their jobs. 

Now, it will be up to the FDA to decide whether or not to follow the recommendation from the Vaccines and Related Biological Products Advisory Committee.

Source link